InvestorsHub Logo
Followers 18
Posts 2517
Boards Moderated 0
Alias Born 05/17/2009

Re: BiotechValues post# 21230

Friday, 01/01/2010 4:41:27 PM

Friday, January 01, 2010 4:41:27 PM

Post# of 94785
In your example of NFEC, it's PEG is kind of misleading with a company that is expected to have 100% growth yoy. Unless they're expected to continue 100% yoy growth in the future...you have a PEG of .12, so if a PEG of 1 is ultimately a well valued company, this should be trading at close to 8x current share price. However, they have a PE of 12, and if next years growth goes to something more like 25%, then you have a stock trading at a PE of 50 (after the 100% growth) and now growing at 25%, so the PEG is suddenly 2 as growth slows.

I think PEG should be calculated based of a longer term growth rate instead of one year, which could be just an anomaly due to an acquisition, new product, etc. If NFEC is expected to continue growing 100% yoy, then this is absolutely correct. However, if it's not a sustainable growth rate then you have to take that into consideration and not expect it to achieve a PEG of 1.. Obviously, it's difficult to know what these companies are going to do 2 and 3 years out, but based on past growth rates you can estimate reasonable growth expectations for the future..

Note, i have no knowledge of NFEC and have no idea what its expected future growth rate is. Just when you see 100% yoy growth, it's typically not sustainable for multiple years even in our Chinese small caps. Thought I'd throw that out..eat me alive if you want. wink

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.